Picture of Mediclinic International logo

MDC Mediclinic International News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge Cap

REG - Official List - Suspension - Mediclinic International plc

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230526:nRSZ6974Aa&default-theme=true

RNS Number : 6974A  Official List  26 May 2023

 NOTICE OF TEMPORARY SUSPENSION OF LISTING FROM THE OFFICIAL LIST
 26/05/2023 07:30
 TEMPORARY SUSPENSION
 Mediclinic International plc
 The Financial Conduct Authority ("the FCA") temporarily suspends the
 securities set out below from the Official List effective from 26/05/2023
 07:30 at the request of the company:

 Security Description                         Listing Category                     ISIN
 Ordinary Shares of GBP0.10 each; fully paid  Premium Equity Commercial Companies  GB00B8HX8Z88 ●

 

 This notice has been issued by Issuer Management - 020 7066 8352.

Notes

SEDOL numbers which are allocated by the London Stock Exchange as a Stock
 Exchange identifier may be found on their dealing notice.

●Denotes the security is being admitted to trading on the London Stock
 Exchange, a Recognised Investment Exchange.

†Denotes the security is also being admitted to trading on Aquis Stock
 Exchange, a Recognised Investment Exchange.

#Denotes the security is also being admitted to trading on Euronext, a
 Recognised Investment Exchange.

 ∼Denotes the security is also being admitted to trading on Cboe Europe, a
 Recognised Investment Exchange.

^Denotes the security is also being admitted to trading on Shanghai-London
 Stock Connect, a Recognised Investment Exchange.

*Denotes the security is also being admitted to trading on IPSX Prime, a
 Recognised Investment Exchange.

Notices issued by the FCA in respect of admission of securities to the
 Official List must be read in conjunction with notices issued by the relevant
 Recognised Investment Exchange in respect of admission of securities to
 trading on its markets.

 

This notice has been issued by Issuer Management - 020 7066 8352.

 

 Notes

SEDOL numbers which are allocated by the London Stock Exchange as a Stock
 Exchange identifier may be found on their dealing notice.

●Denotes the security is being admitted to trading on the London Stock
 Exchange, a Recognised Investment Exchange.

†Denotes the security is also being admitted to trading on Aquis Stock
 Exchange, a Recognised Investment Exchange.

#Denotes the security is also being admitted to trading on Euronext, a
 Recognised Investment Exchange.

 ∼Denotes the security is also being admitted to trading on Cboe Europe, a
 Recognised Investment Exchange.

^Denotes the security is also being admitted to trading on Shanghai-London
 Stock Connect, a Recognised Investment Exchange.

*Denotes the security is also being admitted to trading on IPSX Prime, a
 Recognised Investment Exchange.

Notices issued by the FCA in respect of admission of securities to the
 Official List must be read in conjunction with notices issued by the relevant
 Recognised Investment Exchange in respect of admission of securities to
 trading on its markets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOTFLFLVEEIEFIV

Recent news on Mediclinic International

See all news